• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat.Commun. Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine

tetano

Editor, Senior Moderator
Nat Commun. 2019 Jul 5;10(1):2981. doi: 10.1038/s41467-019-10814-9.
[h=1]Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine.[/h] de Steenhuijsen Piters WAA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Jochems SP[SUP]4[/SUP], Mitsi E[SUP]4[/SUP], Rylance J[SUP]4[/SUP], Pojar S[SUP]4[/SUP], Nikolaou E[SUP]4[/SUP], German EL[SUP]4[/SUP], Holloway M[SUP]4[/SUP], Carniel BF[SUP]4[/SUP], Chu MLJN[SUP]1,[/SUP][SUP]2[/SUP], Arp K[SUP]1,[/SUP][SUP]2[/SUP], Sanders EAM[SUP]1[/SUP], Ferreira DM[SUP]4[/SUP], Bogaert D[SUP]5,[/SUP][SUP]6,[/SUP][SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Streptococcus pneumoniae is the main bacterial pathogen involved in pneumonia. Pneumococcal acquisition and colonization density is probably affected by viral co-infections, the local microbiome composition and mucosal immunity. Here, we report the interactions between live-attenuated influenza vaccine (LAIV), successive pneumococcal challenge, and the healthy adult nasal microbiota and mucosal immunity using an experimental human challenge model. Nasal microbiota profiles at baseline are associated with consecutive pneumococcal carriage outcome (non-carrier, low-dense and high-dense pneumococcal carriage), independent of LAIV co-administration. Corynebacterium/Dolosigranulum-dominated profiles are associated with low-density colonization. Lowest rates of natural viral co-infection at baseline and post-LAIV influenza replication are detected in the low-density carriers. Also, we detected the fewest microbiota perturbations and mucosal cytokine responses in the low-density carriers compared to non-carriers or high-density carriers. These results indicate that the complete respiratory ecosystem affects pneumococcal behaviour following challenge, with low-density carriage representing the most stable ecological state.


PMID: 31278315 PMCID: PMC6611866 DOI: 10.1038/s41467-019-10814-9
 
Back
Top Bottom